v3.25.4
Consolidated Statements of Income (Loss) - USD ($)
$ in Millions
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Revenues:      
Earned Premiums [1] $ (4,396.3) $ (4,215.9) $ (4,529.4)
Net Investment Income 405.0 407.5 419.7
Other (Loss) Income (2.0) 10.5 10.1
Change in Fair Value of Equity and Convertible Securities (4.3) (2.7) 4.7
Net Realized Investment Gains (Losses) 5.5 13.2 (18.6)
Impairment Losses (10.8) (5.8) (1.1)
Total Revenues 4,789.7 4,638.6 4,944.2
Expenses:      
Policyholders’ Benefits and Incurred Losses and Loss Adjustment Expenses [2] (3,375.5) (3,013.1) (3,820.0)
Insurance and Other Expenses 1,215.0 1,180.1 1,365.6
Interest Expense 38.5 56.9 56.1
Goodwill Impairment 0.0 0.0 49.6
Total Expenses 4,629.0 4,250.1 5,291.3
Income (Loss) before Income Taxes 160.7 388.5 (347.1)
Income Tax Expense (Benefit) (28.1) (76.0) 74.8
Net Income (Loss) 132.6 312.5 (272.3)
Less: Net Loss attributable to Noncontrolling Interest (10.7) (5.3) (0.2)
Net Income (Loss) attributable to Kemper Corporation $ 143.3 $ 317.8 $ (272.1)
Net Income (Loss) attributable to Kemper Corporation Per Unrestricted Share:      
Basic (in dollars per share) $ 2.31 $ 4.95 $ (4.25)
Diluted (in dollars per share) $ 2.29 $ 4.91 $ (4.25)
[1]
1 Includes a remeasurement loss related to the deferred profit liability within the Life Insurance business of $8.7 million for the year ended December 31, 2025, a remeasurement loss of $7.2 million for the year ended December 31, 2024, and a remeasurement loss of $19.1 million for the year ended December 31, 2023.
[2]
2 Includes a remeasurement gain related to the liability for future policyholder benefits within the Life Insurance business of $14.3 million for the year ended December 31, 2025, a remeasurement gain of $19.2 million for the year ended December 31, 2024, and a remeasurement gain of $30.3 million for the year ended December 31, 2023.